Skip to main content
. 2020 Oct 31;21(21):8174. doi: 10.3390/ijms21218174
AAA abdominal aortic aneruysm
ALS amyotrophic lateral sclerosis
AngII angiotensin II
APOE apolioprotein E
CAD coronary artery disease
CML chronic myeloid leukemia
DAMP damage-associated molecular patterns
DVT deep vein thrombosis
FADD FAS-associated death domain
HIF1α hypoxia inducible factor-1α
HUVEC human umbilical vein endothelial cells
IFNγ interferon γ
IL1β Interleukin 1β
IVC inferior vena cava
LAD left anterior descending
LDL low-density lipoprotein
LVEF left ventricle ejection fraction
MCAO middle cerebral artery occlusion
MI myocardial infarction
MLKL mixed-lineage kinase domain like protein
MMP matrix metalloproteinase
MS multiple sclerosis
Nec-1/1s necrostain-1/1s
NET neutrophil extracellular trap
NFKβ Nuclear factor kappa β
NSA necrosulfonamide
PCI percutaneous coronary intervention
PE pulmonary embolism
Ph+ ALL Philadelphia chromosome positive acute lymphoblastic leukemia
PI propidium iodide
PTLP phospholipid transfer protein
RA rheumatoid arthritis
RIPK1 receptor interacting protein kinase 1
RIPK3 receptor interacting protein kinase 3
SIRS systemic inflammatory response syndrome
SMC smooth muscle cell
STEMI ST elevation myocardial infarction
STING stimulator of interferon genes
TLR 3/4 toll like receptor 3/4
TNFα tumor necrosis factor α
TNFR1 tumor necrosis factor receptor 1
TRAILR tumor necrosis α related apoptosis inducing ligand receptor
tPA tissue plasminogen activator
UC ulcerative colitis
VTE venous thromboembolism